Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Price | 1d % | 1w % | 1m % | 3m % | 6m % | 1y % | 3y % | 5y % | 10y % | 52-week High | 52-week Low | % off 52-week High | % off 52-week Low | Beta | Volume | Vol 1d % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CZR | CAESARS ENTERTAINMENT INC | $35.33 | 0.54% | -3.50% | -18.46% | -17.36% | -20.43% | -19.74% | -63.54% | -28.84% | N/A | $60.27 | $35.09 | 41.38% | 0.68% | 2.12 | 3,713,578 | -32.62% |
| DCOM | DIME COMMUNITY BANCSHARES INC | $19.40 | 0.41% | 1.68% | 5.95% | -7.44% | -7.04% | 6.83% | -41.86% | -38.76% | -19.33% | $27.91 | $15.57 | 30.48% | 24.60% | 1.14 | 212,596 | 101.09% |
| ALIT | ALIGHT INC | $9.30 | 0.98% | 2.09% | -1.59% | 3.56% | 28.99% | 3.33% | -7.83% | N/A | N/A | $10.38 | $6.33 | 10.40% | 46.92% | 1.06 | 3,673,370 | -22.24% |
| NUVL | NUVALENT INC | $70.35 | -2.95% | 5.22% | -4.93% | -10.26% | 24.84% | 89.42% | N/A | N/A | N/A | $89.39 | $37.13 | 21.30% | 89.47% | 1.71 | 346,463 | 6.36% |
| LRMR | LARIMAR THERAPEUTICS INC | $7.77 | 2.04% | 20.57% | 0.58% | 30.07% | 143.04% | 68.80% | -43.98% | -75.58% | N/A | $13.68 | $2.18 | 43.24% | 256.19% | 0.64 | 231,966 | 5.24% |
| TPST | TEMPEST THERAPEUTICS INC | $3.69 | 4.24% | 4.24% | -28.00% | -7.40% | 0.27% | 84.50% | -79.15% | -98.50% | -99.77% | $9.77 | $0.17 | 62.23% | 2,070.59% | 1.54 | 410,493 | -14.87% |
| NE | NOBLE CORP PLC | $45.29 | 2.77% | -2.16% | -9.60% | 5.47% | -9.87% | 27.47% | N/A | N/A | N/A | $55.34 | $35.29 | 18.16% | 28.34% | 0.84 | 823,841 | 2.49% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.